Get the Stockscreener App
61.78
0.95%
0.575
Overview
News
Price History
Option Chain
Financials
Why CTVA Down?
Discussions
Forecast
Dividend History
Corteva Inc stock is traded at $61.78, with a volume of 1.07M.
It is up +0.95% in the last 24 hours and up +5.93% over the past month.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
See More
Previous Close:
$61.21
Open:
$60.93
24h Volume:
1.07M
Relative Volume:
0.42
Market Cap:
$42.61B
Revenue:
$16.90B
Net Income/Loss:
$898.00M
P/E Ratio:
47.90
EPS:
1.29
Net Cash Flow:
$788.00M
1W Performance:
+1.65%
1M Performance:
+5.93%
6M Performance:
+8.10%
1Y Performance:
+23.02%
1-Day Range:
$60.66
$61.94
1-Week Range:
$60.53
$62.38
52-Week Range:
$43.22
$62.38
Corteva Inc Stock (CTVA) Company Profile
Name
Corteva Inc
Sector
Industry
Phone
(833) 267-8382
Address
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Corteva Inc Stock (CTVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-24 | Downgrade | Argus | Buy → Hold |
| Apr-12-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-01-24 | Initiated | Wolfe Research | Outperform |
| Feb-12-24 | Upgrade | Loop Capital | Hold → Buy |
| Feb-02-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Nov-27-23 | Downgrade | Berenberg | Buy → Hold |
| Nov-14-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-20-23 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-05-23 | Upgrade | UBS | Neutral → Buy |
| Jul-25-23 | Downgrade | Redburn | Buy → Neutral |
| Jun-28-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Upgrade | Vertical Research | Hold → Buy |
| Apr-06-23 | Initiated | Oppenheimer | Perform |
| Jan-19-23 | Initiated | Wells Fargo | Overweight |
| Jan-11-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-16-22 | Downgrade | UBS | Buy → Neutral |
| Nov-15-22 | Downgrade | Loop Capital | Buy → Hold |
| Aug-08-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-08-22 | Upgrade | ROTH Capital | Neutral → Buy |
| Jul-14-22 | Initiated | Credit Suisse | Outperform |
| Jun-01-22 | Initiated | Barclays | Overweight |
| May-06-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-14-22 | Upgrade | Loop Capital | Hold → Buy |
| Apr-14-22 | Downgrade | Vertical Research | Buy → Hold |
| Jan-31-22 | Upgrade | Redburn | Neutral → Buy |
| Oct-18-21 | Downgrade | Loop Capital | Buy → Hold |
| Oct-13-21 | Initiated | Mizuho | Buy |
| Oct-08-21 | Initiated | ROTH Capital | Buy |
| Sep-01-21 | Initiated | Berenberg | Buy |
| Aug-09-21 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
| May-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Apr-19-21 | Upgrade | Loop Capital | Hold → Buy |
| Feb-05-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-05-21 | Reiterated | Monness Crespi & Hardt | Sell |
| Dec-18-20 | Downgrade | Susquehanna | Positive → Neutral |
| Dec-14-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-10-20 | Upgrade | Argus | Hold → Buy |
| Oct-19-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-19-20 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
| Aug-11-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Aug-10-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-13-20 | Upgrade | BofA Securities | Underperform → Buy |
| Jun-26-20 | Initiated | Cleveland Research | Neutral |
| Jun-16-20 | Upgrade | Vertical Research | Hold → Buy |
| Jun-08-20 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
| May-11-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Apr-17-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Apr-17-20 | Upgrade | Loop Capital | Sell → Hold |
| Apr-01-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-31-20 | Upgrade | Susquehanna | Neutral → Positive |
| Mar-26-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-19-20 | Upgrade | Edward Jones | Hold → Buy |
| Mar-13-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-10-20 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
View All
Corteva Inc Stock (CTVA) Latest News
National Pension Service Increases Stock Holdings in Corteva, Inc. (NYSE:CTVA) - MarketBeat
Bionematicides Market Global Forecast: Industry Size - openPR
Corteva Inc. stock rises Monday, outperforms market - MarketWatch
Van ECK Associates Corp Increases Position in Corteva, Inc. (NYSE:CTVA) - MarketBeat
Where are they now: Corteva Agriscience - Indianapolis Business Journal
New York State Common Retirement Fund Has $64.72 Million Stock Position in Corteva, Inc. (NYSE:CTVA) - MarketBeat
Corteva Inc. stock falls Friday, underperforms market - MarketWatch
Postemergence weed control that packs a punch - Agweb Powered by Farm Journal
Insights Into Corteva, Inc. (CTVA) Q3: Wall Street Projections for Key Metrics - Yahoo Finance
The Return Trends At Corteva (NYSE:CTVA) Look Promising - Yahoo Finance
Corteva, Inc. (NYSE:CTVA) Shares Acquired by Assenagon Asset Management S.A. - MarketBeat
Corteva Inc. stock rises Wednesday, outperforms market - MarketWatch
New NovaGraz™ Herbicide Controls Pasture Weeds, Preserves Valuable White Clover and More - Hoard's Dairyman
Analysts Estimate Corteva, Inc. (CTVA) to Report a Decline in Earnings: What to Look Out for - MSN
Corteva : Meet Joe Martin - Marketscreener.com
Corteva (CTVA) Set to Announce Earnings on Wednesday - MarketBeat
Corteva sets dividends for common and preferred stock By Investing.com - Investing.com South Africa
Corteva Inc. stock falls Tuesday, underperforms market - MarketWatch
Corteva (NYSE:CTVA) Hits New 1-Year High After Dividend Announcement - MarketBeat
Corteva, Inc. (NYSE:CTVA) Declares $0.17 Quarterly Dividend - MarketBeat
Corteva sets dividends for common and preferred stock - Investing.com India
Corteva Declares Quarterly Dividend - StockTitan
Mancozeb Market Size 2024-Industry Share, Growth, Trends, - openPR
Corteva, Inc. (NYSE:CTVA) Shares Purchased by Forsta AP Fonden - MarketBeat
Public health advisory cleared for Pittsburg and Antioch after suspected chlorine leak - MSN
What You Need to Know Ahead of Corteva's Earnings Release - MSN
Vidal Warned Of 'Heightened' Burden, 'Loophole' In Seed Fight - Law360
Corteva names new leader for its seed business, including Pioneer operations in Johnston - AOL
IFM Investors Pty Ltd Boosts Stock Position in Corteva, Inc. (NYSE:CTVA) - MarketBeat
Corteva stock soars to 52-week high, hits $61.12 - Investing.com India
Corteva stock soars to 52-week high, hits $61.12 By Investing.com - Investing.com Australia
Raymond James & Associates Has $29.71 Million Position in Corteva, Inc. (NYSE:CTVA) - MarketBeat
Citi bullish on Corteva stock, sees strong EBITDA growth potential By Investing.com - Investing.com Australia
Budding Lessons From Landmark Plant Seed Patent Battle - Law360
Is Corteva, Inc.'s (NYSE:CTVA) Recent Stock Performance Influenced By Its Financials In Any Way? - Simply Wall St
What You Need To Know Ahead Of Corteva's Earnings Release - Barchart
Corteva (NYSE:CTVA) Reaches New 12-Month HighShould You Buy? - MarketBeat
Citigroup Initiates Coverage on Corteva (NYSE:CTVA) - MarketBeat
Citi bullish on Corteva stock, sees strong EBITDA growth potential - Investing.com India
Copeland Capital Management LLC Has $243,000 Stock Holdings in Corteva, Inc. (NYSE:CTVA) - MarketBeat
Evernest Financial Advisors LLC Makes New Investment in Corteva, Inc. (NYSE:CTVA) - MarketBeat
Corteva Inc. stock falls Monday, underperforms market - MarketWatch
Corteva, Inc. (NYSE:CTVA) Shares Acquired by Arlington Partners LLC - MarketBeat
(CTVA) Trading Signals - Stock Traders Daily
Corteva, Inc. (NYSE:CTVA) Shares Bought by Trust Co. of Vermont - MarketBeat
Corteva, Inc. (NYSE:CTVA) Receives $62.21 Consensus Price Target from Analysts - MarketBeat
Corteva Inc. stock rises Friday, outperforms market - MarketWatch
Corteva Tolvera % JL Farmakis IncAd from 2024-10-18 - AgUpdate
Corteva stock hits 52-week high at $59.08 amid robust growth - Investing.com
Corteva (NYSE:CTVA) Hits New 52-Week HighTime to Buy? - MarketBeat
Corteva Inc Stock (CTVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.30%
0.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):